Header 4

Research!America has been tracking and analyzing the various streams of funding that make up the total U.S. investment in health research for a decade, and trends tell us we are headed in the wrong direction.

2012 Investment in Health Research Report 

After declining in FY10-11, health-related R&D spending in the U.S. increased by $4.3 billion (3.5%) in FY11-12 , an increase largely driven by industry, philanthropy and voluntary health associations. Industry spending increased by $2 billion (3%), primarily due to a $1.3 billion (7.2%) increase in R&D spending by biotech companies. There was nominal growth in pharmaceutical and medical technology spending, at 1% and 2.5%, respectively. Pharmaceutical spending appears to be slowly climbing out of a deep dive (FY11 saw a 10.6% drop in spending in contrast to a 1.1% increase in FY12); the biotech industry is trending solidly upward (spending increased 4.7% in FY11 and 7.2% in FY12); and med tech R&D spending growth continued at a slightly slower pace (3.9% in FY11 compared to 2.5% in FY12).

Federal spending also contributed to the overall increase in the R&D spending reported for FY12, but the apparent increase in this category is misleading. The increase is largely due to changes in the classification of existing spending within the National Science Foundation and the Food and Drug Administration ($315 million at NSF and $152 million at FDA) rather than to an actual increase in dollars.

 

2012 Investment in U.S. Health Research—includes trend charts
2011 Investment in U.S. Health Research
—includes trend charts
2010 Investment in U.S. Health Research—includes trend charts
2009 Investment in U.S. Health Research—includes trend charts
2008 Investment in U.S. Health Research—includes trend charts
2007 Investment in U.S. Health Research—includes trend charts
2006 Investment in U.S. Health Research—includes trend charts
2005 Investment in U.S. Health Research
2004 Investment in U.S. Health Research 
2002 Investment in U.S. Health Research 

Please send us feedback on the 2012 U.S. Investment in U.S. Health Research.